🔎 Trials Near Me

Početna › Melanom › Illinois › Chicago

Kliničke studije za Melanom u gradu Chicago, IL

15 studija za Melanom traži sudionike na lokacijama u gradu Chicago i okolici (unutar oko 30 milja). Otvorite studiju da biste vidjeli tko se može priključiti i kako kontaktirati tim studije.

Službeni tekst studije (engleski)

Tražite sudionike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
  • Mount Sinai Hospital Medical Center, Chicago
  • John H Stroger Jr Hospital of Cook County, Chicago
  • University of Illinois, Chicago
  • i još 1
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

U tijeku regrutacijaFaza 2
  • University of Illinois Cancer Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT06172478

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

U tijeku regrutacijaFaza 2
  • Northwestern University, Chicago
  • University of Illinois, Chicago
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT05136196

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

U tijeku regrutacijaFaza 3
  • Northwestern University, Chicago
  • Swedish Covenant Hospital, Chicago
Od 75 godina i više · Oba spola · Ažurirano 24. ruj 2026. · NCT07068074

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

U tijeku regrutacijaFaza 1/2
  • Northwestern University, Chicago
Od 18 godina i više · Oba spola · Ažurirano 31. kol 2026. · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

U tijeku regrutacijaFaza 1/2
  • Lurie Children's Hospital-Chicago, Chicago
12 Months – 30 Years · Oba spola · Ažurirano 25. kol 2026. · NCT04851119

Project: Every Child for Younger Patients With Cancer

U tijeku regrutacijaOpažajna studija
  • Lurie Children's Hospital-Chicago, Chicago
  • Northwestern University, Chicago
  • University of Illinois, Chicago
  • i još 1
Do 25 godina · Oba spola · Ažurirano 25. kol 2026. · NCT02402244

Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions

U tijeku regrutacija
  • Northwestern University, Chicago
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT07556380

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

U tijeku regrutacijaFaza 1/2
  • Call for Information (Investigational Site 0024), Chicago
6 Months – 17 Years · Oba spola · Ažurirano 6. srp 2026. · NCT02332668

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

U tijeku regrutacijaFaza 1/2
  • University of Chicago Medical Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 13. svi 2026. · NCT03686124

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

U tijeku regrutacijaFaza 1/2
  • University of Chicago, Chicago
Od 18 godina i više · Oba spola · Ažurirano 28. tra 2026. · NCT06413680

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

U tijeku regrutacijaFaza 2/3
  • Northwestern Memorial Hospital, Chicago
  • University of Chicago Medical Center, Chicago
Sve dobne skupine · Oba spola · Ažurirano 2. tra 2026. · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

U tijeku regrutacijaOpažajna studija
  • John H Stroger Jr Hospital of Cook County, Chicago
  • Advocate Illinois Masonic Medical Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 17. ožu 2026. · NCT06418204

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

U tijeku regrutacijaOpažajna studija
  • Massive Bio SYNERGY-AI site, Chicago
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

U tijeku regrutacija
  • Advocate Illinois Masonic Medical Center, Chicago
Od 18 godina i više · Oba spola · Ažurirano 27. stu 2024. · NCT03860883

Studije za Melanom u drugim gradovima

Ostale studije u gradu Chicago

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.